Highly Active Antiretroviral Therapy in Resource-Poor Settings
- June 21, 2003. British Medical Journal. Ruairí Brugha.
Antiretroviral treatment in developing countries: the
peril of neglecting private providers.
- June 13, 2003. Journal of the International AIDS Society. Catherine Orrell,
David R. Bangsberg, Motasim Badri, and Robin Wood.
Adherence Is Not a Barrier to Successful Antiretroviral Therapy.
- May 1, 2003. New England Journal of Medicine. Steven J. Reynolds,
John G. Bartlett, Thomas C. Quinn, Chris Beyrer, and Robert C. Bollinger.
Antiretroviral Therapy Where Resources Are Limited.
- July, 2002. Journal of AIDS vol. 16(10): 1363 - 1370.
Christian Laurenta; Ndella Diakhatéb; Ndeye Fatou Ngom Gueyeb; Mame Awa
Touréb; Papa Salif Sowb; Mame Awa Fayeb; Mandoumbé Gueyec; Isabelle
Laniècea; Coumba Touré Kaned; Florian Liégeoisa; Laurence Vergnea;
Souleymane Mboupd; Salif Badianeb; Ibrahima Ndoyee; Eric Delaportea.
The Senegalese government's highly active antiretroviral therapy
initiative: an 18-month follow-up study.
World Health Organization
January, 2003. Kathy Attawell and Jackie Mundy for WHO and the UK's Department
for International Development.
Provision of antiretroviral therapy in resource-limited
settings: a review of experience up to August 2003.
On April 22, 2002, the World Health Organization released the draft report
Scaling Up Antiretroviral Therapy in Resource Limited Settings:
Guidelines for a Public Health Approach. It sets guidelines for HIV
treatment for poor countries. At this time, WHO includues 12 antiretrovirals
on its Essential Drug List.
2003. Toby Kasper, David Coetzee, Francoise Loius, Andrew Boulle, and Katherine
Hildebrand for the Essential Drugs Monitor #32.
Demystifying therapy in resource-poor settings.